CYTOKINETICS, INCORPORATED Additional Paid in Capital, Common Stock
CYTOKINETICS, INCORPORATED (CYTK) had Additional Paid in Capital, Common Stock of $3.72 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-06
- 2026-06-30: Additional Paid in Capital, Common Stock $3.72B.
- 2026-03-31: Additional Paid in Capital, Common Stock $2.87B.
- 2025-12-31: Additional Paid in Capital, Common Stock $2.83B.
- 2025-09-30: Additional Paid in Capital, Common Stock $2.78B.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $3.72B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.87B 10-Q · filed 2026-05-05 |
| 2025-12-31 | $2.83B 10-Q · filed 2026-08-06 |
| 2025-09-30 | $2.78B 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.63B 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.60B 10-Q · filed 2025-05-06 |
| 2024-12-31 | $2.56B 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.53B 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.50B 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.85B 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.73B 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.54B 10-Q · filed 2023-11-03 |
| 2023-06-30 | $1.51B 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.49B 10-Q · filed 2023-05-05 |
| 2022-12-31 | $1.48B 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.44B 10-Q · filed 2022-11-04 |
| 2022-06-30 | $1.42B 10-Q · filed 2022-08-05 |
| 2022-03-31 | $1.41B 10-Q · filed 2022-05-06 |
| 2021-12-31 | $1.45B 10-K · filed 2023-03-01 |
| 2021-09-30 | $1.43B 10-Q · filed 2021-11-05 |
| 2021-06-30 | $1.12B 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.11B 10-Q · filed 2021-05-07 |
| 2020-12-31 | $1.11B 10-K · filed 2022-02-25 |
| 2020-09-30 | $1.10B 10-Q · filed 2020-11-06 |
| 2020-06-30 | $865.72M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $857.04M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $853.34M 10-K · filed 2021-02-26 |
| 2019-09-30 | $813.73M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $799.09M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $775.40M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $768.70M 10-K · filed 2020-03-04 |
| 2018-09-30 | $765.97M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $762.89M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $757.40M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $755.53M 10-K · filed 2019-03-07 |
| 2017-09-30 | $752.15M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $748.27M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $639.51M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $612.47M 10-K · filed 2018-03-05 |
| 2016-09-30 | $609.88M 10-Q/A · filed 2016-12-15 |
| 2016-06-30 | $607.29M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $604.91M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $603.14M 10-K · filed 2017-03-06 |
| 2015-09-30 | $592.76M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $591.48M 10-Q · filed 2015-08-05 |
| 2014-12-31 | $589.27M 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |